1 Pneumonia Treatment Drugs Market Overview 1.1 Product Overview and Scope of Pneumonia Treatment Drugs 1.2 Pneumonia Treatment Drugs Segment by Type 1.2.1 Global Pneumonia Treatment Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Macrolides 1.2.3 Cephalosporin 1.2.4 Penicillin 1.2.5 Tetracyclines 1.2.6 Fluoroquinolones 1.2.7 Vancomycin 1.2.8 Other Antibiotics 1.2.9 Immunotherapy Drug 1.2.10 Vaccines 1.2.11 Interferon 1.3 Pneumonia Treatment Drugs Segment by Application 1.3.1 Global Pneumonia Treatment Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Drugstore 1.4 Global Pneumonia Treatment Drugs Market Size Estimates and Forecasts 1.4.1 Global Pneumonia Treatment Drugs Revenue 2016-2027 1.4.2 Global Pneumonia Treatment Drugs Sales 2016-2027 1.4.3 Pneumonia Treatment Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Pneumonia Treatment Drugs Market Competition by Manufacturers 2.1 Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Pneumonia Treatment Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Pneumonia Treatment Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Pneumonia Treatment Drugs Manufacturing Sites, Area Served, Product Type 2.5 Pneumonia Treatment Drugs Market Competitive Situation and Trends 2.5.1 Pneumonia Treatment Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Pneumonia Treatment Drugs Players Market Share by Revenue 2.5.3 Global Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Pneumonia Treatment Drugs Retrospective Market Scenario by Region 3.1 Global Pneumonia Treatment Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Pneumonia Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Pneumonia Treatment Drugs Market Facts & Figures by Country 3.3.1 North America Pneumonia Treatment Drugs Sales by Country 3.3.2 North America Pneumonia Treatment Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Pneumonia Treatment Drugs Market Facts & Figures by Country 3.4.1 Europe Pneumonia Treatment Drugs Sales by Country 3.4.2 Europe Pneumonia Treatment Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pneumonia Treatment Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Pneumonia Treatment Drugs Sales by Region 3.5.2 Asia Pacific Pneumonia Treatment Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Pneumonia Treatment Drugs Market Facts & Figures by Country 3.6.1 Latin America Pneumonia Treatment Drugs Sales by Country 3.6.2 Latin America Pneumonia Treatment Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Pneumonia Treatment Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Pneumonia Treatment Drugs Sales by Country 3.7.2 Middle East and Africa Pneumonia Treatment Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Pneumonia Treatment Drugs Historic Market Analysis by Type 4.1 Global Pneumonia Treatment Drugs Sales Market Share by Type (2016-2021) 4.2 Global Pneumonia Treatment Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Pneumonia Treatment Drugs Price by Type (2016-2021) 5 Global Pneumonia Treatment Drugs Historic Market Analysis by Application 5.1 Global Pneumonia Treatment Drugs Sales Market Share by Application (2016-2021) 5.2 Global Pneumonia Treatment Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Pneumonia Treatment Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Corporation Information 6.1.2 GlaxoSmithKline Description and Business Overview 6.1.3 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio 6.1.5 GlaxoSmithKline Recent Developments/Updates 6.2 MSD 6.2.1 MSD Corporation Information 6.2.2 MSD Description and Business Overview 6.2.3 MSD Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 MSD Pneumonia Treatment Drugs Product Portfolio 6.2.5 MSD Recent Developments/Updates 6.3 Mylan 6.3.1 Mylan Corporation Information 6.3.2 Mylan Description and Business Overview 6.3.3 Mylan Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Mylan Pneumonia Treatment Drugs Product Portfolio 6.3.5 Mylan Recent Developments/Updates 6.4 Novartis 6.4.1 Novartis Corporation Information 6.4.2 Novartis Description and Business Overview 6.4.3 Novartis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Novartis Pneumonia Treatment Drugs Product Portfolio 6.4.5 Novartis Recent Developments/Updates 6.5 Pfizer 6.5.1 Pfizer Corporation Information 6.5.2 Pfizer Description and Business Overview 6.5.3 Pfizer Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Pneumonia Treatment Drugs Product Portfolio 6.5.5 Pfizer Recent Developments/Updates 6.6 Teva Pharmaceutical 6.6.1 Teva Pharmaceutical Corporation Information 6.6.2 Teva Pharmaceutical Description and Business Overview 6.6.3 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio 6.6.5 Teva Pharmaceutical Recent Developments/Updates 6.7 Arsanis 6.6.1 Arsanis Corporation Information 6.6.2 Arsanis Description and Business Overview 6.6.3 Arsanis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Arsanis Pneumonia Treatment Drugs Product Portfolio 6.7.5 Arsanis Recent Developments/Updates 6.8 AstraZeneca 6.8.1 AstraZeneca Corporation Information 6.8.2 AstraZeneca Description and Business Overview 6.8.3 AstraZeneca Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 AstraZeneca Pneumonia Treatment Drugs Product Portfolio 6.8.5 AstraZeneca Recent Developments/Updates 6.9 Combioxin 6.9.1 Combioxin Corporation Information 6.9.2 Combioxin Description and Business Overview 6.9.3 Combioxin Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Combioxin Pneumonia Treatment Drugs Product Portfolio 6.9.5 Combioxin Recent Developments/Updates 6.10 Shinogi 6.10.1 Shinogi Corporation Information 6.10.2 Shinogi Description and Business Overview 6.10.3 Shinogi Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Shinogi Pneumonia Treatment Drugs Product Portfolio 6.10.5 Shinogi Recent Developments/Updates 6.11 Sun Pharmaceutical 6.11.1 Sun Pharmaceutical Corporation Information 6.11.2 Sun Pharmaceutical Pneumonia Treatment Drugs Description and Business Overview 6.11.3 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio 6.11.5 Sun Pharmaceutical Recent Developments/Updates 6.12 Medicines 6.12.1 Medicines Corporation Information 6.12.2 Medicines Pneumonia Treatment Drugs Description and Business Overview 6.12.3 Medicines Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Medicines Pneumonia Treatment Drugs Product Portfolio 6.12.5 Medicines Recent Developments/Updates 6.13 Theravance Biopharma 6.13.1 Theravance Biopharma Corporation Information 6.13.2 Theravance Biopharma Pneumonia Treatment Drugs Description and Business Overview 6.13.3 Theravance Biopharma Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio 6.13.5 Theravance Biopharma Recent Developments/Updates 7 Pneumonia Treatment Drugs Manufacturing Cost Analysis 7.1 Pneumonia Treatment Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pneumonia Treatment Drugs 7.4 Pneumonia Treatment Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pneumonia Treatment Drugs Distributors List 8.3 Pneumonia Treatment Drugs Customers 9 Pneumonia Treatment Drugs Market Dynamics 9.1 Pneumonia Treatment Drugs Industry Trends 9.2 Pneumonia Treatment Drugs Growth Drivers 9.3 Pneumonia Treatment Drugs Market Challenges 9.4 Pneumonia Treatment Drugs Market Restraints 10 Global Market Forecast 10.1 Pneumonia Treatment Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pneumonia Treatment Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Pneumonia Treatment Drugs by Type (2022-2027) 10.2 Pneumonia Treatment Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pneumonia Treatment Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Pneumonia Treatment Drugs by Application (2022-2027) 10.3 Pneumonia Treatment Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pneumonia Treatment Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Pneumonia Treatment Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Pneumonia Treatment Drugs Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Pneumonia Treatment Drugs Sales (MT) Comparison by Application (2021-2027) Table 3. Global Pneumonia Treatment Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Pneumonia Treatment Drugs Covered in This Study Table 5. Global Pneumonia Treatment Drugs Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Pneumonia Treatment Drugs Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Pneumonia Treatment Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Pneumonia Treatment Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pneumonia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Treatment Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Pneumonia Treatment Drugs Sales by Region (2016-2021) & (MT) Table 16. Global Pneumonia Treatment Drugs Sales Market Share by Region (2016-2021) Table 17. Global Pneumonia Treatment Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Pneumonia Treatment Drugs Sales by Country (2016-2021) & (MT) Table 19. North America Pneumonia Treatment Drugs Sales Market Share by Country (2016-2021) Table 20. North America Pneumonia Treatment Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Pneumonia Treatment Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Pneumonia Treatment Drugs Sales by Country (2016-2021) & (MT) Table 23. Europe Pneumonia Treatment Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Pneumonia Treatment Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Pneumonia Treatment Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Pneumonia Treatment Drugs Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Pneumonia Treatment Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Pneumonia Treatment Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Pneumonia Treatment Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Pneumonia Treatment Drugs Sales by Country (2016-2021) & (MT) Table 31. Latin America Pneumonia Treatment Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Pneumonia Treatment Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Pneumonia Treatment Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Pneumonia Treatment Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Pneumonia Treatment Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Pneumonia Treatment Drugs Sales (MT) by Type (2016-2021) Table 39. Global Pneumonia Treatment Drugs Sales Market Share by Type (2016-2021) Table 40. Global Pneumonia Treatment Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Pneumonia Treatment Drugs Revenue Share by Type (2016-2021) Table 42. Global Pneumonia Treatment Drugs Price (USD/MT) by Type (2016-2021) Table 43. Global Pneumonia Treatment Drugs Sales (MT) by Application (2016-2021) Table 44. Global Pneumonia Treatment Drugs Sales Market Share by Application (2016-2021) Table 45. Global Pneumonia Treatment Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Pneumonia Treatment Drugs Revenue Share by Application (2016-2021) Table 47. Global Pneumonia Treatment Drugs Price (USD/MT) by Application (2016-2021) Table 48. GlaxoSmithKline Corporation Information Table 49. GlaxoSmithKline Description and Business Overview Table 50. GlaxoSmithKline Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. GlaxoSmithKline Pneumonia Treatment Drugs Product Table 52. GlaxoSmithKline Recent Developments/Updates Table 53. MSD Corporation Information Table 54. MSD Description and Business Overview Table 55. MSD Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. MSD Pneumonia Treatment Drugs Product Table 57. MSD Recent Developments/Updates Table 58. Mylan Corporation Information Table 59. Mylan Description and Business Overview Table 60. Mylan Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Mylan Pneumonia Treatment Drugs Product Table 62. Mylan Recent Developments/Updates Table 63. Novartis Corporation Information Table 64. Novartis Description and Business Overview Table 65. Novartis Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Novartis Pneumonia Treatment Drugs Product Table 67. Novartis Recent Developments/Updates Table 68. Pfizer Corporation Information Table 69. Pfizer Description and Business Overview Table 70. Pfizer Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Pfizer Pneumonia Treatment Drugs Product Table 72. Pfizer Recent Developments/Updates Table 73. Teva Pharmaceutical Corporation Information Table 74. Teva Pharmaceutical Description and Business Overview Table 75. Teva Pharmaceutical Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Teva Pharmaceutical Pneumonia Treatment Drugs Product Table 77. Teva Pharmaceutical Recent Developments/Updates Table 78. Arsanis Corporation Information Table 79. Arsanis Description and Business Overview Table 80. Arsanis Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Arsanis Pneumonia Treatment Drugs Product Table 82. Arsanis Recent Developments/Updates Table 83. AstraZeneca Corporation Information Table 84. AstraZeneca Description and Business Overview Table 85. AstraZeneca Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. AstraZeneca Pneumonia Treatment Drugs Product Table 87. AstraZeneca Recent Developments/Updates Table 88. Combioxin Corporation Information Table 89. Combioxin Description and Business Overview Table 90. Combioxin Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Combioxin Pneumonia Treatment Drugs Product Table 92. Combioxin Recent Developments/Updates Table 93. Shinogi Corporation Information Table 94. Shinogi Description and Business Overview Table 95. Shinogi Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Shinogi Pneumonia Treatment Drugs Product Table 97. Shinogi Recent Developments/Updates Table 98. Sun Pharmaceutical Corporation Information Table 99. Sun Pharmaceutical Description and Business Overview Table 100. Sun Pharmaceutical Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Sun Pharmaceutical Pneumonia Treatment Drugs Product Table 102. Sun Pharmaceutical Recent Developments/Updates Table 103. Medicines Corporation Information Table 104. Medicines Description and Business Overview Table 105. Medicines Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 106. Medicines Pneumonia Treatment Drugs Product Table 107. Medicines Recent Developments/Updates Table 108. Theravance Biopharma Corporation Information Table 109. Theravance Biopharma Description and Business Overview Table 110. Theravance Biopharma Pneumonia Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 111. Theravance Biopharma Pneumonia Treatment Drugs Product Table 112. Theravance Biopharma Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Pneumonia Treatment Drugs Distributors List Table 116. Pneumonia Treatment Drugs Customers List Table 117. Pneumonia Treatment Drugs Market Trends Table 118. Pneumonia Treatment Drugs Growth Drivers Table 119. Pneumonia Treatment Drugs Market Challenges Table 120. Pneumonia Treatment Drugs Market Restraints Table 121. Global Pneumonia Treatment Drugs Sales Forecast by Type (2022-2027) & (MT) Table 122. Global Pneumonia Treatment Drugs Sales Market Share Forecast by Type (2022-2027) Table 123. Global Pneumonia Treatment Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 124. Global Pneumonia Treatment Drugs Revenue Market Share Forecast by Type (2022-2027) Table 125. Global Pneumonia Treatment Drugs Sales Forecast by Application (2022-2027) & (MT) Table 126. Global Pneumonia Treatment Drugs Sales Market Share Forecast by Application (2022-2027) Table 127. Global Pneumonia Treatment Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 128. Global Pneumonia Treatment Drugs Revenue Market Share Forecast by Application (2022-2027) Table 129. Global Pneumonia Treatment Drugs Sales Forecast by Region (2022-2027) & (MT) Table 130. Global Pneumonia Treatment Drugs Sales Market Share Forecast by Region (2022-2027) Table 131. Global Pneumonia Treatment Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 132. Global Pneumonia Treatment Drugs Revenue Market Share Forecast by Region (2022-2027) Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Pneumonia Treatment Drugs Figure 2. Global Pneumonia Treatment Drugs Market Share by Type in 2020 & 2027 Figure 3. Macrolides Product Picture Figure 4. Cephalosporin Product Picture Figure 5. Penicillin Product Picture Figure 6. Tetracyclines Product Picture Figure 7. Fluoroquinolones Product Picture Figure 8. Vancomycin Product Picture Figure 9. Other Antibiotics Product Picture Figure 10. Immunotherapy Drug Product Picture Figure 11. Vaccines Product Picture Figure 12. Interferon Product Picture Figure 13. Global Pneumonia Treatment Drugs Market Share by Application in 2020 & 2027 Figure 14. Hospital Figure 15. Clinic Figure 16. Drugstore Figure 17. Global Pneumonia Treatment Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Pneumonia Treatment Drugs Market Size 2016-2027 (US$ Million) Figure 19. Global Pneumonia Treatment Drugs Sales 2016-2027 (MT) Figure 20. Global Pneumonia Treatment Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 21. Pneumonia Treatment Drugs Sales Share by Manufacturers in 2020 Figure 22. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers in 2020 Figure 23. The Global 5 and 10 Largest Pneumonia Treatment Drugs Players: Market Share by Revenue in 2020 Figure 24. Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 25. Global Pneumonia Treatment Drugs Sales Market Share by Region (2016-2021) Figure 26. Global Pneumonia Treatment Drugs Sales Market Share by Region in 2020 Figure 27. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2016-2021) Figure 28. Global Pneumonia Treatment Drugs Revenue Market Share by Region in 2020 Figure 29. U.S. Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Canada Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Germany Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. France Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. U.K. Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Italy Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Russia Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. China Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Japan Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. South Korea Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. India Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Australia Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Taiwan Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Indonesia Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Thailand Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Malaysia Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Philippines Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Vietnam Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Mexico Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Brazil Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Argentina Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Turkey Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Saudi Arabia Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.A.E Pneumonia Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. Sales Market Share of Pneumonia Treatment Drugs by Type (2016-2021) Figure 54. Sales Market Share of Pneumonia Treatment Drugs by Application (2016-2021) Figure 55. Sales Market Share of Pneumonia Treatment Drugs by Application in 2020 Figure 56. Revenue Share of Pneumonia Treatment Drugs by Application (2016-2021) Figure 57. Revenue Share of Pneumonia Treatment Drugs by Application in 2020 Figure 58. Manufacturing Cost Structure of Pneumonia Treatment Drugs Figure 59. Manufacturing Process Analysis of Pneumonia Treatment Drugs Figure 60. Pneumonia Treatment Drugs Industrial Chain Analysis Figure 61. Channels of Distribution Figure 62. Distributors Profiles Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

GlaxoSmithKline MSD Mylan Novartis Pfizer Teva Pharmaceutical Arsanis AstraZeneca Combioxin Shinogi Sun Pharmaceutical Medicines Theravance Biopharma